References
1. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol. 2017;35(18):2082-2094.
2. Kara SS, Tezer H, Polat M, et al. Risk factors for bacteremia in children with febrile neutropenia. Turk J Med Sci. 2019;49(4):1198-1205.
3. Koçak U, Rolston KV, Mullen CA. Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia. Support Care Cancer. 2002;10(1):58-64.
4. Gustinetti G, Mikulska M. Bloodstream infections in neutropenic cancer patients: A practical update. Virulence. 2016;7(3):280-297.
5. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol. 1996;14(3):919-924.
6. Ammann RA, Hirt A, Lüthy AR, Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003;41(5):436-443.
7. Ammann RA, Bodmer N, Hirt A, et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol. 2010;28(12):2008-2014.
8. Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002;24(1):38-42.
9. Rondinelli PI, Ribeiro KeC, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28(10):665-670.
10. Santolaya ME, Alvarez AM, Avilés CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002;35(6):678-683.
11. Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92(4):909-913.
12. Weinkove R, Clay J, Wood C. Temperature management in haematology patients with febrile neutropenia: a practice survey. N Z Med J. 2013;126(1373):62-73.
13. Weinkove R, Bowden E, Wood C, et al. A randomized controlled feasibility trial of paracetamol during febrile neutropenia in hemato-oncology patients. Leuk Lymphoma. 2019;60(6):1540-1547.
14. Dokko D. Best practice for fever management with intravenous acetaminophen in pediatric oncology. J Pediatr Oncol Nurs. 2015;32(2):120-125.
15. Hakim H, Flynn PM, Srivastava DK, et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010;29(1):53-59.
16. Alali M, Mayampurath A, Dai Y, Bartlett AH. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia. Sci Rep. 2022;12(1):7429.
17. Ammann RA, Hirt A, Lüthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J. 2004;23(1):61-67.
18. Phillips RS, Sung L, Ammann RA, et al. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer. 2016;114(12):e17.
19. Janssens KP, Valete COS, Silva ARAD, Ferman SE. Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia. J Pediatr (Rio J). 2021;97(3):302-308.
20. Haeusler GM, Thursky KA, Slavin MA, et al. Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules. EClinicalMedicine. 2020;18:100220.
21. Ojha RP, Asdahl PH, Steyerberg EW, Schroeder H. Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model. Pediatr Blood Cancer. 2018;65(4).
22. Haeusler GM, Phillips R, Slavin MA, et al. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia. EClinicalMedicine. 2020;23:100394.
23. Das A, Trehan A, Oberoi S, Bansal D. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India. Pediatr Blood Cancer. 2017;64(6).
24. Miedema KG, Tissing WJ, Abbink FC, et al. Risk-adapted approach for fever and neutropenia in paediatric cancer patients–a national multicentre study. Eur J Cancer. 2016;53:16-24.
25. Phillips B. Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia. F1000Res. 2021;10:1070.
26. Klaassen RJ, Goodman TR, Pham B, Doyle JJ. ”Low-risk” prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18(5):1012-1019.